Secondly, although the conclusion of p53 expression and chemosensitivity to platinum drugs in advanced NSCLC was confirmed in our study, relatively few studies were included and the sample size was small, which may lead to bias to some extent. Here, TP53 is linked to non-small cell lung carcinoma.